Akèy › Sklerodèm › North Carolina › Durham
Etid klinik pou Sklerodèm nan Durham, NC
7 etid pou Sklerodèm ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Duke University Medical Center, Durham
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Ap rekriteFaz 1
- University of North Carolina TraCS Institute - CTRC, Chapel Hill · 10 mi lwen
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Duke University Medical Center, Durham
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- Duke University, Durham
A Study of AZD0120 in Autoimmune Diseases
Ap rekriteFaz 1
- Research Site, Chapel Hill · 10 mi lwen
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
- Duke University, Durham
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Ap rekriteFaz 1
- Duke University Health System, Durham
Etid Sklerodèm nan lòt vil
- New York City, NY11 etid
- Ann Arbor, MI10 etid
- Chicago, IL10 etid
- Houston, TX9 etid
- Los Angeles, CA7 etid
- Boston, MA7 etid
- New Orleans, LA6 etid
- Philadelphia, PA6 etid
- Baltimore, MD6 etid
- Dallas, TX5 etid
- Pittsburgh, PA5 etid
- Miami, FL4 etid
Lòt etid nan Durham
- Kansè nan tete63 etid
- Kansè (tout kalite)59 etid
- Kansè Poumon ki pa ti selil39 etid
- Myelom Miltip37 etid
- Kansè Metastatik33 etid
- Leksemi mieloïd egi33 etid
- Kansè poumon32 etid
- Kansè pwostat32 etid
- Kansè kolorektal28 etid
- Kansè ovè27 etid
- Lukemi lenfositè kwonik27 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.